Pediatric clinical trial update: July 2026

July's clinical trial news spanned a wide range of pediatric subspecialties, from a large real-world comparison of biologics in inflammatory bowel disease to early-phase pharmacokinetic work in atopic dermatitis, exploratory biomarker findings in Fontan-associated liver disease, and dueling readouts in food allergy and ADHD therapeutics. Several reports came from ongoing trial programs building on already-approved therapies, while others offered early looks at agents still years from a regulatory decision.